Value Bridge — UNIVERSITY OF VERMONT MEDICAL CENTER
Current $-65M → Target $-37M (+$28.9M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-65.5M
Current EBITDA
$-36.5M
Target EBITDA
+$28.9M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$6.5M
Payer Mix Optimization
$15.7M
Cost to Collect Reduction
$5.2M
Clean Claim Improvement
$3.9M
Volume & Rate Growth
$26.2M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-65M to $-37M. The highest-impact lever is Volume & Rate Growth at $10.5M probability-weighted.
IC talking point: "We see $29M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $318M in equity value creation."